Filing Details
- Accession Number:
- 0001628280-25-038322
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-06 16:07:25
- Reporting Period:
- 2025-08-06
- Filing Date:
- 2025-08-06
- Accepted Time:
- 2025-08-06 16:07:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1582393 | P. Anthony Zook | 9490 Neogenomics Way Fort Myers FL 33912 | Chief Executive Officer | Yes | Yes | No | No |
Transaction Summary
| Purchased: | 17,900 shares | Avg. Price: $5.58 | Total Value: $99,953.60 |
| Number of Shares After Transactions: | 38,066 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-08-06 | 17,900 | $5.58 | 38,066 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 18,900 | Indirect | Amended and Restated Anthony P. Zook Living Trust |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $14.82 | 2024-08-10 | 2033-08-10 | 8,353 | 8,353 | Direct |
| Common Stock | Stock Option (Right to Buy) | $13.71 | 2025-06-01 | 2034-06-01 | 8,672 | 8,672 | Direct |
| Common Stock | Stock Option (Right to Buy) | $10.44 | 2035-04-01 | 729,927 | 729,927 | Direct | |
| Common Stock | Restricted Stock Unit | $0.00 | 421,496 | 421,496 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2033-08-10 | 8,353 | 8,353 | Direct |
| 2034-06-01 | 8,672 | 8,672 | Direct |
| 2035-04-01 | 729,927 | 729,927 | Direct |
| 421,496 | 421,496 | Direct |
Footnotes
- This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.
- On April 1, 2025, Mr. Zook was granted 729,927 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- Once vested, the shares of common stock are not subject to expiration.
Billionaire Hedge Funds
